|Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis|
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML van der Kop, ...
JAMA: The Journal of the American Medical Association 308 (3), 247-256, 2012
|Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies|
ME Karim, P Gustafson, J Petkau, H Tremlett, ...
American journal of epidemiology 184 (4), 325-335, 2016
|Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort|
ME Karim, P Gustafson, J Petkau, Y Zhao, A Shirani, E Kingwell, C Evans, ...
American journal of epidemiology 180 (2), 160-171, 2014
|Multiple sclerosis in older adults: the clinical profile and impact of interferon beta treatment|
A Shirani, Y Zhao, J Petkau, P Gustafson, ME Karim, C Evans, E Kingwell, ...
BioMed research international 2015, 2015
|Role of nonsteroidal antiinflammatory drugs in the association between osteoarthritis and cardiovascular diseases: a longitudinal study|
M Atiquzzaman, ME Karim, J Kopec, H Wong, AH Anis
Arthritis & Rheumatology 71 (11), 1835-1843, 2019
|Beta‐interferon exposure and onset of secondary progressive multiple sclerosis|
T Zhang, A Shirani, Y Zhao, ME Karim, P Gustafson, J Petkau, C Evans, ...
European journal of neurology 22 (6), 990-1000, 2015
|Can we train machine learning methods to outperform the high-dimensional propensity score algorithm?|
ME Karim, M Pang, RW Platt
Epidemiology 29 (2), 191-198, 2018
|Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis|
K Ahmed, T McVeigh, R Cerneviciute, S Mohamed, M Tubassam, M Karim, ...
BMC nephrology 19 (1), 1-18, 2018
|Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review …|
S Kanters, M Vitoria, M Zoratti, M Doherty, M Penazzato, A Rangaraj, ...
EClinicalMedicine 28, 100573, 2020
|Nurses “seeing forest for the trees” in the age of machine learning: using nursing knowledge to improve relevance and performance|
JY Kwon, ME Karim, M Topaz, LM Currie
CIN: Computers, Informatics, Nursing 37 (4), 203-212, 2019
|Estimating inverse probability weights using super learner when weight‐model specification is unknown in a marginal structural Cox model context|
ME Karim, RW Platt, BeAMS Study Group
Statistics in medicine 36 (13), 2032-2047, 2017
|A higher antibody response is generated with a 6-to 7-week (vs standard) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine dosing interval|
B Grunau, M Asamoah-Boaheng, PM Lavoie, ME Karim, TL Kirkham, ...
Clinical Infectious Diseases 75 (1), e888-e891, 2022
|Determinants of antibiotic tailoring in pediatric intensive care: A national survey|
PS Fontela, C Quach, ME Karim, DF Willson, E Gilfoyle, JD McNally, ...
Pediatric Critical Care Medicine 18 (9), e395-e405, 2017
|Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study|
P Liu, RR Quinn, ME Karim, A Bello, H Tam-Tham, R Weaver, ...
Cmaj 191 (10), E274-E282, 2019
|Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies|
ME Karim, J Petkau, P Gustafson, RW Platt, H Tremlett, ...
Statistical methods in medical research 27 (6), 1709-1722, 2018
|On the application of statistical learning approaches to construct inverse probability weights in marginal structural cox models: hedging against weight-model misspecification|
ME Karim, J Petkau, P Gustafson, H Tremlett, TBS Group
Communications in Statistics-Simulation and Computation 46 (10), 7668-7697, 2017
|Are perceived barriers to accessing health care associated with inadequate antenatal care visits among women of reproductive age in Rwanda?|
MP Nisingizwe, G Tuyisenge, C Hategeka, ME Karim
BMC pregnancy and childbirth 20 (1), 1-10, 2020
|Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study|
A Shirani, Y Zhao, ME Karim, J Petkau, P Gustafson, C Evans, E Kingwell, ...
European Journal of Neurology 21 (6), 835-844, 2014
|Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia …|
M Piske, T Thomson, E Krebs, N Hongdilokkul, J Bruneau, S Greenland, ...
BMJ open 10 (9), e036102, 2020
|A pragmatic randomized controlled trial testing the effects of the international scientific SCI exercise guidelines on SCI chronic pain: protocol for the EPIC-SCI trial|
KA Martin Ginis, JW van der Scheer, KR Todd, JC Davis, S Gaudet, ...
Spinal Cord 58 (7), 746-754, 2020